Credit: ABC News

After infamous pharmaceutical executive Martin Shkreli increased the cost of a life-saving HIV drug by 5000 percent, a group of Australian high school students created a replica – that costs $2 to make. You read that right — ONLY $2.

Shkreli is well-known (and well-hated) for raising the cost of Daraprim from $13.50 a pill to a whopping $750.

“While the drug is out of patent, Martin’s Turing Pharmaceuticals controls its distribution and sale through a loophole called the ‘closed distribution model’,” University of Sydney Associate Professor Matthew Todd told the Herald. “To take the drug to market as a generic, you need to compare it to Turing’s product. If Turing won’t allow the comparisons to take place, you’d need to fund a whole new trial.”

If high school students can make the drug in a lab for $2, Shkreli has no business selling it for $750. Good work, boys.